Stem Cell Science in Action: NYSCF Introduces New Drug Discovery Platform at SNF Nostos Conference
“My colleagues and I are delighted to bring the NYSCF lab to you here at SNF Nostos Health today, and to show you in real time...
58 Results
Clear Filters
When Good Brain Cells Go Bad: New Findings from NYSCF and Johns Hopkins Precision Medicine Initiative
The Context: Astrocytes are support cells in the brain that help our neurons function properly. However, these typically helpful cells can ‘go rogue’ or ‘reactive’ in...
Replacing the Brain’s Cleanup Machinery to Treat Neurological Disease
The Context: Microglia are resident immune cells of the brain that are constantly patrolling the central nervous system to eliminate dead or damaged cells. Defects in...
2021 in Review
2021 has been a banner year for science. With your support, we opened a new laboratory for creating clinical-grade cells to treat blindness, created stem cell...
Translating Discoveries into Medicine, Advancing Equity in Science, and New Cancer Therapies: Watch Highlights of the 2021 NYSCF Conference
On October 19th and 20th, we hosted the sixteenth annual NYSCF Conference on translational stem cell research. This year’s meeting, held virtually for the second consecutive...
Showing Up For Science: Highlights of the NYSCF Gala
On October 5th, celebrities, scientists, and supporters ‘showed up for science’ at the The 2021 New York Stem Cell Foundation Gala. Hosted by CNN’s Chief Medical...
The Stem Cell Science You Won’t Want to Miss at The NYSCF Conference
Annually for the past 15 years, the NYSCF Conference has showcased the latest cutting-edge findings in translational stem cell research, gathering world-renowned multi-disciplinary speakers and 500+...
Amplifying Patient Voices to Drive Multiple Sclerosis Research
Every multiple sclerosis (MS) patient has a different experience, and understanding these experiences is imperative for effectively treating all patients. How can we repair the neurodegeneration...
A Clearer Window Into Disease: Meet the Opera Phenix Microscope
At the root of every major disease of our time is the simple question: what is going wrong with our cells? Once scientists know exactly how...
Valentina Fossati Explains Why We Sent Patient Cells to Space
Cover photo: Dr. Valentina Fossati (NYSCF) and Jason Stein (Aspen Neuroscience) prepare cells for launch. Photo credit: Space Tango Why send cells affected by multiple sclerosis...
Showing Up for Science: Celebrities and Stem Cells Take Center Stage at the NYSCF Gala
Hosted by CNN’s Chief Medical Correspondent Sanjay Gupta, MD, this year’s New York Stem Cell Foundation Research Institute Gala & Science Fair went virtual for the...
Does Brain Inflammation Trigger Neurodegeneration? If So, it Could Open the Door for New Therapies
Today, more than 6 million Americans suffer from neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and multiple sclerosis, and as our society ages, that number is only...
NYSCF Scientists Create the ‘Stars’ of the Brain and Capture Their Rogue Behavior in Disease
Read the press release here. You may not have heard of astrocytes before, but your body is full of them: they make up more than...
When Astrocytes Attack: Stem Cell Model Shows Possible Mechanism Behind Neurodegeneration
Human stem-cell-derived astrocytes can be triggered to become toxic to neurons, opening the door for new understanding and treatment of neurodegenerative diseases. Featured image credit: Christina...
NYSCF Scientists Talk Space, Stem Cells, and their Pioneering Study of MS and PD
The International Space Station (ISS) houses more than astronauts: the football-field-sized spacecraft is also home to a large range of research projects carried out in the...
2019 in Review
As we enter 2020, we’re taking a moment to look back at the incredible advancements of 2019. From forming new precision medicine partnerships to sending multiple...
NYSCF Collaboration Sends Multiple Sclerosis and Parkinson’s Disease Brain Cells to Space
Brain cells derived from the stem cells of multiple sclerosis and Parkinson’s disease patients are on their way up to the International Space Station! This afternoon,...
First-in-kind Human 3-dimensional Models of Parkinson’s Disease and Progressive Multiple Sclerosis Launching to the International Space Station
First patient-derived, induced pluripotent stem cell disease-specific organoid models in microgravity to advance understanding of neurodegenerative disease LOUISVILLE, KY — (BUSINESS WIRE) — The National Stem...
NYSCF, Johns Hopkins, and Bloomberg Philanthropies Partner to Advance Precision Medicine
A new collaboration between the NYSCF Research Institute, Johns Hopkins University School of Medicine (JHUSOM), and Bloomberg Philanthropies is aiming to push precision medicine forward using...
Bloomberg Philanthropies, Johns Hopkins University School of Medicine, and The New York Stem Cell Foundation Research Institute Announce an Unprecedented Effort to Advance Precision Medicine
Unmatched Scope of Resources Will Identify Distinctive Disease Mechanisms in Small Patient Subgroups, Supporting Development of Custom Therapeutic Approaches New York, NY (October 22, 2019) –...
New Hope for a Rare and Deadly Neurological Disease
The Context: Pelizaeus – Merzbacher disease (PMD) is a rare neurological condition typically diagnosed in infancy which often becomes fatal by a patient’s teenage years. While...
Stem Cells Take to Space: NYSCF Collaboration Launches the First 3D Models of Parkinson’s Disease and Multiple Sclerosis to the International Space Station
On Thursday evening, SpaceX cargo flight CRS-18 took off from Cape Canaveral, bound for the International Space Station (ISS). Aboard for the 250-mile journey were brain...
NYSCF Collaboration Finds Possible Mechanism Behind Tired Brain Cells in Progressive MS
The Context: In multiple sclerosis (MS), brain cells degenerate and malfunction, leaving patients with symptoms such as numbness, weakness, vision loss, tremor, fatigue, and cognitive impairment....
The Science of Startups: Drs. Derrick Rossi and Paul Tesar Discuss How Their Biotechs Are Bringing Stem Cell Research to Patients
“We had the foundational tools we needed to move our research from academia to biotech,” remarked NYSCF – Robertson Investigator Alumnus Dr. Paul Tesar. “We had...
NYSCF Collaboration Uncovers New Target for Progressive Multiple Sclerosis Therapies
The Context: In multiple sclerosis, the immune system attacks myelin (the fatty substance that surrounds neurons and helps them send signals). Currently, there are no...